Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Nanjing Ruijie Pharma discloses new NR1H4 agonists

Jan. 5, 2021

Promising phase II data presented for BT-11 in ulcerative colitis

Jan. 5, 2021

B cell transcription factor helps gut regenerate

Jan. 4, 2021

FDA clears LyGenesis' IND for phase IIa study of cell therapy for end-stage liver disease

Dec. 31, 2020

Altimmune initiates phase II trial of HepTcell for chronic hepatitis B

Dec. 31, 2020

Saroglitazar magnesium approved in India for NAFLD

Dec. 31, 2020

Hepion reports topline low-dose data from phase IIa trial of CRV-431 in NASH

Dec. 30, 2020

First subject dosed in phase I study of ASC-42

Dec. 28, 2020

OSE initiates phase II trial of OSE-127 in ulcerative colitis

Dec. 22, 2020

Metacrine reports phase I data on FXR agonist MET-642

Dec. 21, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Recombinant vaccine inhibits HBV-associated HCC growth
BioWorld Science
Chronic liver disease and hepatocellular carcinoma (HCC) associated with chronic hepatitis B virus (HBV) are serious health problems in highly endemic areas....